Browse hierarchy: [Microbiology (MI)](/submissions/MI) → [Subpart D — Serological Reagents](/submissions/MI/subpart-d%E2%80%94serological-reagents) → [21 CFR 866.3300](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3300) → MCC — Dna-Probe, Haemophilus Spp.

# MCC · Dna-Probe, Haemophilus Spp.

_Microbiology · 21 CFR 866.3300 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MCC

## Overview

- **Product Code:** MCC
- **Device Name:** Dna-Probe, Haemophilus Spp.
- **Regulation:** [21 CFR 866.3300](/submissions/MI/subpart-d%E2%80%94serological-reagents/866.3300)
- **Device Class:** 2
- **Review Panel:** [Microbiology](/submissions/MI)

## Identification

Haemophilus spp. serological reagents are devices that consist of antigens and antisera, including antisera conjugated with a fluorescent dye, that are used in serological tests to identify Haemophilus spp. directly from clinical specimens or tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of diseases caused by bacteria belonging to the genus Haemophilus and provides epidemiological information on diseases cause by these microorganisms. Diseases most often caused by Haemophilus spp. include pneumonia, pharyngitis, sinusitis, vaginitis, chancroid venereal disease, and a contagious form of conjunctivitis (inflammation of eyelid membranes).

## Classification Rationale

Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 866.9.

## Recent Cleared Devices (2 of 2)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [K901397](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MCC/K901397.md) | ACCUPROBE LISTERIA MONOCYTOGENES CULTURE CONFIRMA. | Gen-Probe, Inc. | Jun 20, 1990 | SESE |
| [K897079](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MCC/K897079.md) | ACCUPROBE HAEOMPHILUS INFLUENZAE CULTURE | Gen-Probe, Inc. | Mar 8, 1990 | SESE |

## Top Applicants

- Gen-Probe, Inc. — 2 clearances

---

**Source:** [https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MCC](https://fda.innolitics.com/submissions/MI/subpart-d%E2%80%94serological-reagents/MCC)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com